Evidence map›Paper›PMID 40005166›Full record

ArticleMolecules (Basel, Switzerland)2025

Exploring the Effects of Sweet Potato Leaves on Skin Health-From Antimicrobial to Immunomodulator.

Manuela Machado, Sara Silva, Manuela Pintado, Eduardo M Costa

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manuela MachadoUniversidade Católica Portuguesa, CBQF Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0002-7705-2293
Sara SilvaUniversidade Católica Portuguesa, CBQF Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0001-8268-2137
Manuela PintadoUniversidade Católica Portuguesa, CBQF Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0002-0760-3184
Eduardo M CostaUniversidade Católica Portuguesa, CBQF Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0003-3121-4514

Funding

Fundação para a Ciência e Tecnologia https://doi.org/10.54499/2022.07206.CEECIND/CP1745/CT0003Fundação para a Ciência e Tecnologia UIDB/50016/2020
6 · The paper itself

Abstract

Sweet potato leaves (SPL), an agricultural byproduct, hold significant potential in dermatological applications due to their bioactive compounds. This study evaluates the phenolic profile of SPL extracts and investigates their biological activities relevant to skin health. Extract fingerprinting, through uHPLC-DAD and LC-MS, identified phenolic acids and flavonoids, with cynarin, neochlorogenic acid, and spiraeoside being predominant. The presence of hyperoside was detected. From a biological standpoint, SPL demonstrated notable antimicrobial activity, with MICs ranging from 2.5 to 5 mg/mL against various bacterial strains, such as MRSA and

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsImmunologic FactorsIpomoea batatasPlant ExtractsPlant LeavesSkinBiofilmsHumansKeratinocytesMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial AgentsAnti-Infective AgentsImmunologic FactorsPlant Extractsantimicrobial activitybiofilm inhibitioncytotoxicityimmunomodulationphenolic compoundssweet potato leaves

Identifiers

PMID40005166
PMCPMC11858553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.